Viking Therapeutics
ent_17b8dba7f913e24b9acbf009
Disclosures
2
Leak Site · 1 jurisdiction
Incidents
—
no linked incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
2
unverified actor claims
Identity resolution
- Canonical name
- Viking Therapeutics
- Normalized
- viking therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- vikingtherapeutics.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2023-12-19
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
- GLOBALLeak Siteas victim2023-12-18